In this article, we discuss 10 Stocks That Tanked: Why Larry Robbins’ Top Picks Are Struggling in 2026.
Larry Robbins is the founder, CEO, and portfolio manager of Glenview Capital Management, a New York-based hedge fund he launched in 2000. A protégé of Leon Cooperman at Omega Advisors, Robbins built Glenview into one of the industry’s most prominent Tiger Cub descendants, specifically known for a concentrated, research-intensive approach to growth-at-a-reasonable-price (GARP) investing. While Robbins is a diversified investor, he is most famously associated with the healthcare sector. His investment thesis often centers on predictable businesses, managed care providers, hospital chains, and pharmaceutical distributors, that he believes are undervalued by the broader market.
READ MORE: Billionaire Tom Steyer’s 10 Stock Picks with Huge Upside Potential and 10 Best Small-Cap Value Stocks to Buy According to Bares Capital.
His conviction is legendary. Robbins is known for maintaining massive positions even during periods of extreme volatility. This was most notable in 2015 when, after a period of significant underperformance, Robbins took the rare step of writing a candid letter to investors apologizing for the losses of the fund and declining his management fee for a period to realign his interests with his partners. While he generally avoids the hostile public theatrics of traditional corporate raiders, he frequently engages with management teams to suggest strategic shifts, such as spin-offs, share repurchases, or improved capital allocation.
Our Methodology
For this article, we selected stocks by combing through the 13F portfolio of Glenview Capital at the end of the fourth quarter of 2025. The stocks were ranked according to the year-to-date decline in share price and the top 10 from this list were filtered out. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2025 database of 1041 elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Larry Robbins of Glenview Capital
Stocks That Tanked: Why Larry Robbins’ Top Picks Are Struggling in 2026
10. Global Payments Inc. (NYSE:GPN)
YTD Decline in Share Price: 10%
Glenview Capital’s Stake: $458 million
Global Payments Inc. (NYSE:GPN) has been a consistent feature in the 13F portfolio of Glenview Capital for the past several years. The fund first disclosed a stake in the company back in the third quarter of 2013. This position comprised just under 3 million shares. By the third quarter of 2014, the fund had grown this stake to over 4.5 million shares. Thereafter, it trimmed the holding and sold it off completely by the middle of 2015. A new position in the firm was opened in the fourth quarter of 2020. This consisted of over 60,000 shares. Filings for the fourth quarter of 2025 show that the fund owned 5.9 million shares in the company, up 15% compared to filings for the previous quarter.
Global Payments Inc. (NYSE:GPN) recently completed the purchase of Worldpay. In the May 6 earnings call, CEO Cameron Bready highlighted that the Worldpay integration was unlocking cross-sell opportunities that were previously inaccessible, specifically in the enterprise restaurant segment. Management expects at least $200 million in revenue synergies from these strategies. However, analysts contend that the firm is viewed by investors as a legacy incumbent that is being squeezed by more agile, tech-first rivals. As payment processing becomes increasingly commoditized, Global Payments may be forced to compete on price to retain its 6 million merchant locations, which could permanently compress its long-term margins despite current synergy targets.
